European PE firm, Sigla, has invested in Bredehorst Clinic Medical Management (BCMM), a provider of healthcare procurement optimisation services in Germany.
Founded in 2006, BCMM improves the purchasing of German healthcare providers, particularly hospitals. It is the only provider in Germany covering all non-personnel cost categories. The firm has approximately 60 specialists, has completed over 180 engagements, and works with many of Germany’s most prominent hospital groups and care associations.
“The demands on hospitals and social care providers are growing enormously,” said Kim Königer, managing partner and co-founder, BCMM. “What our clients need from a partner like BCMM is no longer simply cost reduction, it is a broader, deeper engagement which addresses procurement quality, supply security, and increasingly the data and digital infrastructure that sits behind every purchasing decision. [With Sigla] we will be able to bring our clients a more comprehensive set of solutions than we could on our own.”
BCMM and Sigla will work to accelerate expansion and to digitalise BCMM’s operations.
“German hospitals are under financial pressure, making BCMM’s services more critical than ever,” said Karl Geisel, managing partner, Sigla. “Demand for BCMM’s services is high. Our ambition with Kim and Philipp will be to increase BCMM’s own capacity to serve this demand.”
The investment comes from Sigla Fund I.
“With the right investment in people, technology, and selective adjacencies, we see a strong basis for acceleration in BCMM’s core business and for service scope expansion,” said Phil Lesjak, managing partner, Sigla.
Sigla is backed by Nordstjernan, a Swedish family-controlled and foundation-owned investment house.
